MMCAP INFUSE Notice RFP 32581 Pharmaceutical Wholesaler Distribution Srvs

MMCAP Infuse, a national cooperative purchasing group operated by the State of Minnesota, is seeking proposals for Pharmaceutical Wholesaler Distribution Services through RFP 32581. The procurement targets national or regional distributors capable of serving multiple states, with a focus on providing prescription and over-the-counter medications, pharmacy supplies, and related services. Respondents must demonstrate capabilities in picking, packing, and shipping pharmaceuticals in compliance with regulatory requirements, as well as offering customer service, account management, inventory management, online ordering, and delivery support. Key evaluation criteria include corporate overview, account management, inventory processes, ordering systems, picking and delivery mechanisms, invoicing, reporting capabilities, and product availability and cost. The original proposal due date of April 13, 2023, was extended to May 5, 2023, through Addendum 2, with contract negotiations anticipated to begin in the second quarter of 2023 and a potential contract start in the fourth quarter of 2023 or early 2024. Prospective bidders must be able to serve a minimum of 5 states and possess appropriate licensing for pharmaceutical distribution.

The RFP does not explicitly outline specific set-aside designations or restrictions for disadvantaged enterprises. MMCAP Infuse represents a collective purchasing group with an annual purchasing power exceeding $1.7 billion, serving state, county, and local government facilities across the United States. The organization will award contracts to one or more responsive and responsible bidders whose proposals are deemed most advantageous. A consistent feature of the procurement is the 3% administrative fee, which is negotiable and will not apply to 340B purchases. While specific budget ranges are not detailed, the RFP suggests significant potential contract value given the broad membership and anticipated growth of the purchasing cooperative. Respondents will be required to provide comprehensive reporting, including personalized financial scorecards demonstrating overall state savings, and must comply with the Drug Supply Chain Security Act. The procurement aims to establish an initial two-year contract with options to extend for three additional years, providing substantial long-term opportunities for qualified pharmaceutical wholesaler distributors.